Microkeratome Market size was valued at USD 678.90 million in 2021 and is expected to reach USD 1876.72 million by 2028, at a CAGR of 10.0% during the forecast period 2022-2028. A microkeratome is a high-precision surgical equipment that consists of an oscillating blade that is used to generate the corneal flap for refractive surgery, and is particularly useful in ALK and LASIK procedures. A healthy human cornea is approximately 500 and 600 millimetres thick. The microkeratome forms an 83200 m thick flap in the LASIK procedure. Descemet’s Stripping Automated Endothelial Keratoplasty (DSAEK) uses a microkeratome to cut a reedy layer from the back of the cornea, which is subsequently moved into the inheritor’s cornea. The vacuum and microkeratome units are built, thoroughly tested, and examined prior to the start of surgery to ensure proper operation. this report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, The global Microkeratome Market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global Microkeratome Market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities).
In February 2017, Johnson & Johnson completed the acquisition of Abbott Medical Optics.